Li JunJie, Shao ZhiMin
Department of Breast Surgery, Shanghai Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Springerplus. 2015 Oct 15;4:615. doi: 10.1186/s40064-015-1394-8. eCollection 2015.
Less developed countries (LDCs) are struggling with an increasing burden of breast cancer. It is important to identify what interventions might be most effective and feasible in reducing overall breast cancer mortality in a resource constrained settings. Mammography screening (MS) utilized in developed countries cannot be equally applied to LDCs. We provide a summary of the status of existing and past MS program attempts in LDCs, and try to determine the prerequisites under which any developing country is ready to benefit from a MS program. We make the case for a "mixed" portfolio of tools to reduce breast cancer mortality with MS reserved only for those sub-populations that meet the criteria. We hope our review will provide a background for policy makers to apply rigorous criteria before attempting to implement costly MS program and before judiciously evaluating additional competed programs in their countries.
欠发达国家（LDCs）正面临着日益加重的乳腺癌负担。确定在资源有限的情况下哪些干预措施可能最有效且可行，对于降低总体乳腺癌死亡率至关重要。发达国家所采用的乳腺钼靶筛查（MS）无法同等应用于欠发达国家。我们总结了欠发达国家现有和过去乳腺钼靶筛查项目尝试的状况，并试图确定任何发展中国家准备好从乳腺钼靶筛查项目中获益的先决条件。我们主张采用“混合”工具组合来降低乳腺癌死亡率，乳腺钼靶筛查仅保留给那些符合标准的亚人群。我们希望我们的综述能为政策制定者在试图实施成本高昂的乳腺钼靶筛查项目之前，以及在审慎评估其国家其他相互竞争的项目之前，应用严格标准提供背景依据。
